SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001558370-19-002961
Filing Date
2019-04-12
Accepted
2019-04-12 16:08:39
Documents
5
Effectiveness Date
2019-04-12

Document Format Files

Seq Description Document Type Size
1 DEFA14A defa14a.htm DEFA14A 23495
2 GRAPHIC defa14ag001.gif GRAPHIC 39903
3 GRAPHIC defa14ag002.gif GRAPHIC 65290
4 GRAPHIC defa14ag003.gif GRAPHIC 14619
5 GRAPHIC defa14ag004.gif GRAPHIC 3284
  Complete submission text file 0001558370-19-002961.txt   194472
Mailing Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453
Business Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453 781-996-5252
Kala Pharmaceuticals, Inc. (Filer) CIK: 0001479419 (see all company filings)

IRS No.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38150 | Film No.: 19746373
SIC: 2834 Pharmaceutical Preparations